Product Information
STIMULANT LAXATIVE PLUS TABLET is a generic product labeled by Rugby Laboratories, priced at $0.0297 per EA under NDC 00536124801. Its NADAC has been published 346 times since Feb 19, 2020.
Strength
50; 8.6 mg/1; mg/1
Manufacturer
Rugby LaboratoriesNDC
00536124801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOCUSATE SODIUM; SENNOSIDESApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
10/22/2019
Price Statistics
The NADAC for STIMULANT LAXATIVE PLUS TABLET has been published 346 times since Feb 19, 2020, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0297 per EA |
|---|---|
| All-time high | $0.0388 (Mar 11, 2020) |
| All-time low | $0.0233 (Dec 20, 2023) |
| 52-week high | $0.0327 |
| 52-week low | $0.0297 |
| Median price | $0.0306 |
| Average price | $0.0305 |
| Largest weekly change | -25.1% (Dec 20, 2023) |
| Weeks tracked | 346 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Docusate Sodium 50 mg and Sennosides 8.6 mg market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of STIMULANT LAXATIVE PLUS TABLET?
The current National Average Drug Acquisition Cost (NADAC) for STIMULANT LAXATIVE PLUS TABLET, manufactured by Rugby Laboratories, is $0.0297 per EA (NDC 00536124801), effective Sep 30, 2026.
How has the price of STIMULANT LAXATIVE PLUS TABLET changed over time?
Over the history we have for it, the NADAC for STIMULANT LAXATIVE PLUS TABLET has declined 23.4%. It has been tracked across 346 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for STIMULANT LAXATIVE PLUS TABLET?
Since Feb 19, 2020, the NADAC for STIMULANT LAXATIVE PLUS TABLET has ranged from a low of $0.0233 (Dec 20, 2023) to a high of $0.0388 (Mar 11, 2020), with a median of $0.0306 per EA.
Are there cheaper alternatives to STIMULANT LAXATIVE PLUS TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as STIMULANT LAXATIVE PLUS TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures STIMULANT LAXATIVE PLUS TABLET?
STIMULANT LAXATIVE PLUS TABLET (NDC 00536124801) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.